Advantages of FBPA PET in evaluating early response of anti-PD-1 immunotherapy in B16F10 melanoma-bearing mice: Comparison to FDG PET

Advantages of FBPA PET in evaluating early response of anti-PD-1 immunotherapy in B16F10 melanoma-bearing mice: Comparison to FDG PET

PurposePET with L-4-borono-2-[18F] fluoro-phenylalanine (FBPA) was reported to be useful to differentiate malignant tumors and inflammation. Although immunotherapy with immune checkpoint inhibitors (ICIs) has been applied to cancer treatment recently, FDG PET may not be suitable to determine the eff...

Full description

Bibliographic Details
Main Authors: Mitsuaki Tatsumi, Fumihiko Soeda, Sadahiro Naka, Kenta Kurimoto, Kazuhiro Ooe, Hideyuki Fukui, Daisuke Katayama, Tadashi Watabe, Hiroki Kato, Noriyuki Tomiyama
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Oncology
Subjects:
immune checkpoint inhibitor
melanoma
mouse
FBPA
FDG
PET
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1026608/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1026608/full

Similar Items